New Trends in Pharmacology & Drug Development

Aurora kinases control multiple events during cell cycle progression and are essential for mitotic and meiotic bipolar spindle assembly and function. There are three aurora kinases in mammals, some of which have oncogenic properties and all of which are overexpressed in multiple cancers 2.The kinetics of drug binding to gpcrs are complex and depend on several factors, including charge distribution on the receptor surface, ligand–receptor interactions in the binding channel and the binding site, or solvation. Previously, drugs were developed focusing on target affinity and selectivity. However, it is becoming evident that the drug–target residence time, related to the off-rate, is an important parameter for successful drug development. The residence time influences both the on-rate and overall effectiveness of drugs. Due to recent efforts in the development of fast computers, md simulations and related techniques allow calculation of the binding pathways of ligands and estimation of rate constants 3. Protease-activated receptors (pars) are a ubiquitously expressed class of g-protein-coupled receptors (gpcrs) that enable cells to respond to proteases in the extracellular environment in a nuanced and dynamic manner. Two agents targeting par1, recombinant activated protein c and vorapaxar, are US FDA approved. However, their use has been limited by questions of efficacy and safety, respectively.
 

  • Binding kinetics and pathways of ligands to GPCRs
  • Aurora A kinase ,a priority pharmaceutical target for treatment of cancer
  • Novel adjuvants designed for improving vaccine efficacy
  • Targetting Protease-activated receptors(PAR1)
  • Risks associated with new drug development

Related Conference of New Trends in Pharmacology & Drug Development

(10 Plenary Forums-1Event)
November 02-03, 2017

18th World Conference and Exhibition on Analytical & Bioanalytical Chromatographic Techniques

Atlanta, Georgia, USA
November 15-16, 2017

2nd International Conference on Nuclear Chemistry


(10 Plenary Forums - 1Event)
Las Vegas, Nevada, USA
March 01 - 03, 2018

4th European Organic Chemistry Congress

London,UK
May 17-19, 2018

11th Global Experts Meeting on Chemistry

Singapore
July 23-24, 2018 Lisbon, Portugal

9th Global Chemistry Congress

8th European Chemistry Congress

June 21-23, 2018 Paris, France
July 23-24, 2018

11th Annual Congress on Chemistry

Melbourne, Australia
October 29-30, 2018

3rd International Conference on Pharmaceutical Chemistry

Brussels, Belgium
October 22-23 , 2018

24th World Chemistry & System Biology Conference

Toronto,Ontario, Canada
November 05-06, 2018

International Conference on Catalysis and Pyrolysis 2018 (ICCP-2018)


(10 Plenary Forums - 1Event)
San Francisco, USA
Dec 03-04, 2018

Chemistry & Drug Discovery 2018

Mexico City, Mexico

New Trends in Pharmacology & Drug Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in